Clues to recognition of fumarate hydratase‐deficient renal cell carcinoma: Findings from cytologic and limited biopsy samples
Authors:
- 19 October 2018
- journal article
- research article
- Published by Wiley in Cancer Cytopathology
- Vol. 126 (12) , 992-1002
Abstract
Background: Fumarate hydratase (FH)‐deficient renal cell carcinoma (RCC) is rare and highly aggressive and is believed to arise mostly in the setting of hereditary leiomyomatosis‐RCC syndrome with a germline mutation of FH. Because of the aggressiveness of these tumors and a frequent lack of ascertainable family history, these tumors may first present as metastases and be sampled by cytology. The cytologic findings of FH‐deficient RCC have not previously been reported.Methods: Cytologic and limited biopsy samples from patients with FH‐deficient RCC were reviewed retrospectively.Results: In total, 24 cytologic and limited biopsy samples from 19 patients (6 women and 13 men; age range, 22‐69 years) who had FH‐deficient RCC and metastasis at presentation were evaluated. These included 21 cytology samples ranging from malignant effusions (n = 7) to metastases (n = 11), to samples of primary kidney tumors (n = 3). The samples exhibited cells, often in clusters and abortive papillae, with voluminous, finely vacuolated cytoplasm and large, pleomorphic nuclei with prominent, viral inclusion‐like nucleoli. A distinctive finding of peripheral cytoplasmic clearing frequently was apparent, and intranuclear cytoplasmic pseudoinclusions were less frequent. Of 7 cell block and biopsy samples, several of which represented sampling from the same patient, all demonstrated tissue fragments that had discernable morphologic patterns associated with FH‐deficient RCC, including tubulocystic and intracystic papillary growth.Conclusions: Features characteristic and suggestive of FH‐deficient RCC may be identified in cytologic and small biopsy samples. Although the current samples were identified retrospectively in well characterized cases of FH‐deficient RCC, the authors argue that, with appropriate clinical correlation, these features are sufficiently distinctive to trigger recognition and confirmatory workup.Keywords
This publication has 24 references indexed in Scilit:
- Outcome of genetic evaluation of patients with kidney cancer referred for suspected hereditary cancer syndromesUrologic Oncology: Seminars and Original Investigations, 2016
- Comprehensive Molecular Characterization of Papillary Renal-Cell CarcinomaNew England Journal of Medicine, 2016
- Diagnosis of Metastatic Renal Cell Carcinoma on Fine-Needle Aspiration CytologyArchives of Pathology & Laboratory Medicine, 2014
- Best Practices Recommendations in the Application of Immunohistochemistry in the Kidney TumorsAmerican Journal of Surgical Pathology, 2014
- Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome–associated Renal CancerAmerican Journal of Surgical Pathology, 2014
- Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC)American Journal of Surgical Pathology, 2014
- The Morphologic Spectrum of Kidney Tumors in Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC) SyndromeAmerican Journal of Surgical Pathology, 2007
- Fine-needle aspiration of a Xp11.2 translocation/TFE3 fusion renal cell carcinoma metastatic to the lung: Report of a case and review of the literatureDiagnostic Cytopathology, 2006
- Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancerNature Genetics, 2002
- Cytologic analysis of papillary renal cell carcinomaCancer, 1998